SCHEMBL7415932

SCHEMBL7415932

COC(=O)c1ccc2c(C(=O)C(C)C)c(CC(C)C)n(Cc3ccccc3Cl)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.43
TP53 P04637 1/20 0.43
S1PR3 Q99500 2/20 0.43
ALOX5AP P20292 8/20 0.43
DPP4 P27487 2/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
ALOX5 P09917 2/20 0.41
LTC4S Q16873 2/20 0.41
PTGES O14684 1/20 0.41
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PLA2G2A P14555 1/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
TLR8 Q9NR97 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7468891 0.91 MAPT (0.44) MAPTTP53S1PR3ALOX5APDPP4
SCHEMBL7418990 0.91 MAPT (0.44) MAPTTP53S1PR3ALOX5APDPP4
SCHEMBL7425401 0.90 MAPT (0.43) MAPTTP53S1PR3ALOX5APDPP4
SCHEMBL7418727 0.89 ALOX5AP (0.53) ALOX5APDPP4KDM4EALOX5LTC4S
SCHEMBL7426945 0.88 ALOX5AP (0.54) TP53ALOX5APDPP4ALDH1A1ALOX5
SCHEMBL7471087 0.87 L3MBTL1 (0.49) MAPTTP53S1PR3DPP4KDM4E
SCHEMBL8557370 0.84 TP53 (0.43) MAPTTP53S1PR3ALOX5APDPP4
SCHEMBL7476760 0.83 MAPT (0.44) MAPTTP53S1PR3ALOX5APDPP4
SCHEMBL7418494 0.83 MAPT (0.44) MAPTTP53S1PR3ALOX5APDPP4
SCHEMBL7472045 0.82 ALOX5AP (0.46) MAPTTP53ALOX5APDPP4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed